Advanced Bionics Receives Worldwide Approval for HiRes Optima Strategy

Advanced Bionics announces regulatory approval from FDA, Health Canada, and TÜV for HiRes Optima.

HiRes Optima is a modification of the HiRes Fidelity 120 strategy, and is intended to optimize power efficiency. This new strategy improves battery life without compromising the listening benefits of the HiResolution bionic ear system. AB cochlear implant recipients using this new technology enjoy an average improvement of 55% in battery life, giving them considerably more time to hear their world before needing to change a battery.